C12N 2710/10043
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2710/10043 (Viral genome or elements thereof as genetic vector) appears on 323 US grants and 647 published applications in this corpus.
Search patents in C12N- Granted patents
- 323
- Published applications
- 647
- Assignees
- 321
- Inventors
- 1,143
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 1 |
| 2002 | 3 | 2 |
| 2003 | 2 | 3 |
| 2004 | 1 | 4 |
| 2005 | 2 | 10 |
| 2006 | 1 | 12 |
| 2007 | 1 | 8 |
| 2008 | 3 | 8 |
| 2009 | 3 | 11 |
| 2010 | 4 | 9 |
| 2011 | 4 | 10 |
| 2012 | 3 | 13 |
| 2013 | 4 | 17 |
| 2014 | 12 | 21 |
| 2015 | 18 | 40 |
| 2016 | 23 | 57 |
| 2017 | 24 | 43 |
| 2018 | 31 | 38 |
| 2019 | 29 | 52 |
| 2020 | 25 | 40 |
| 2021 | 26 | 36 |
| 2022 | 28 | 42 |
| 2023 | 17 | 35 |
| 2024 | 20 | 43 |
| 2025 | 20 | 47 |
| 2026 | 16 | 45 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Combination immunotherapy15 Sep 2026US 12,735,466 B2The Regents of the University of California
- Compositions and methods for recombinant parvovirus production15 Sep 2026US 12,735,724 B2Aavnergene Inc.
- Sequential heterologous boost oncolytic viral immunotherapy25 Aug 2026US 12,714,733 B2Children's Hospital of Eastern Ontario Research Institute Inc.
- Engineered adenovirus vectors and uses thereof18 Aug 2026US 12,709,761 B2
- One-step method for producing adenoviral vectors14 Jul 2026US 12,680,110 B2The University of Chicago
- Materials and methods for increasing immune responses within a mammal8 Oct 2026US 2026/0306668 A1Mayo Foundation for Medical Education and Research
- Fusion proteins of il-24 and immunostimulatory cytokines, nk cells expressing il-24 or fusion proteins, and methods of use thereof8 Oct 2026US 2026/0308218 A1Virginia Commonwealth University
- Expression cassette coding for vascular endothelial growth factor8 Oct 2026US 2026/0308618 A1Cornell University
- Compositions and Methods for Increasing AAV Productivity8 Oct 2026US 2026/0308624 A1Oxford Biomedica (US) LLC
- Engineered adenovirus vectors and uses thereof8 Oct 2026US 2026/0308629 A1
Most cited
By later US patents
- Methods for rapid PEG-modification of viral vectors, compositions for enhanced gene transduction, compositions with enhanced physical stability, and uses therefor90US 6,399,385 B1The Trustees of the University of Pennsylvania · 2002
- Adeno associated virus plasmids and vectors62US 9,677,088 B2Oregon Health & Science University · 2017
- Optical tissue interface method and apparatus for stimulating cells51US 9,238,150 B2The Board of Trustees of the Leland Stanford Junior University · 2016
- Subfamily E simian adenoviruses A1321, A1325, A1295, A1309, A1316 and A1322 and uses thereof48US 8,834,863 B2The Trustees of the University of Pennsylvania · 2014
- Antiviral vaccines with improved cellular immunogenicity48US 9,017,691 B2Beth Israel Deaconess Medical Center, Inc. · 2015